237 related articles for article (PubMed ID: 12506103)
41. Comparative effects of the nonsteroidal anti-inflammatory drug nepafenac on corneal sensory nerve fibers responding to chemical irritation.
Acosta MC; Luna C; Graff G; Meseguer VM; Viana F; Gallar J; Belmonte C
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):182-8. PubMed ID: 17197531
[TBL] [Abstract][Full Text] [Related]
42. Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice.
Vinores SA; Derevjanik NL; Vinores MA; Okamoto N; Campochiaro PA
Adv Exp Med Biol; 2000; 476():129-38. PubMed ID: 10949661
[TBL] [Abstract][Full Text] [Related]
43. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Duong HV; Westfield KC; Chalkley TH
J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
[TBL] [Abstract][Full Text] [Related]
44. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
[TBL] [Abstract][Full Text] [Related]
45. A novel and effective human hepatocyte growth factor kringle 1 domain inhibits ocular neovascularization.
Lu Q; Zhang L; Shen X; Zhu Y; Zhang Q; Zhou Q; Gan R; Zhang H; Zhong Y; Xie B
Exp Eye Res; 2012 Dec; 105():15-20. PubMed ID: 23085338
[TBL] [Abstract][Full Text] [Related]
46. The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.
Zeng M; Shen J; Liu Y; Lu LY; Ding K; Fortmann SD; Khan M; Wang J; Hackett SF; Semenza GL; Campochiaro PA
J Mol Med (Berl); 2017 Apr; 95(4):417-429. PubMed ID: 28004126
[TBL] [Abstract][Full Text] [Related]
47. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
Ozaki H; Seo MS; Ozaki K; Yamada H; Yamada E; Okamoto N; Hofmann F; Wood JM; Campochiaro PA
Am J Pathol; 2000 Feb; 156(2):697-707. PubMed ID: 10666398
[TBL] [Abstract][Full Text] [Related]
48. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
49. Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.
Kim SJ; Toma HS; Barnett JM; Penn JS
Exp Eye Res; 2010 Oct; 91(4):537-43. PubMed ID: 20659449
[TBL] [Abstract][Full Text] [Related]
50. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
51. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
[TBL] [Abstract][Full Text] [Related]
52. Essential role of growth hormone in ischemia-induced retinal neovascularization.
Smith LE; Kopchick JJ; Chen W; Knapp J; Kinose F; Daley D; Foley E; Smith RG; Schaeffer JM
Science; 1997 Jun; 276(5319):1706-9. PubMed ID: 9180082
[TBL] [Abstract][Full Text] [Related]
53. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.
Schwesinger C; Yee C; Rohan RM; Joussen AM; Fernandez A; Meyer TN; Poulaki V; Ma JJ; Redmond TM; Liu S; Adamis AP; D'Amato RJ
Am J Pathol; 2001 Mar; 158(3):1161-72. PubMed ID: 11238064
[TBL] [Abstract][Full Text] [Related]
54. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
Lane SS; Modi SS; Lehmann RP; Holland EJ
J Cataract Refract Surg; 2007 Jan; 33(1):53-8. PubMed ID: 17189793
[TBL] [Abstract][Full Text] [Related]
55. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.
Jones BM; Neville MW
Ann Pharmacother; 2013 Jun; 47(6):892-6. PubMed ID: 23715071
[TBL] [Abstract][Full Text] [Related]
56. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
Ozaki NK; Beharry KD; Nishihara KC; Akmal Y; Ang JG; Sheikh R; Modanlou HD
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873
[TBL] [Abstract][Full Text] [Related]
57. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
[TBL] [Abstract][Full Text] [Related]
58. An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization.
Xie B; Shen J; Dong A; Swaim M; Hackett SF; Wyder L; Worpenberg S; Barbieri S; Campochiaro PA
FASEB J; 2008 Aug; 22(8):2775-83. PubMed ID: 18381816
[TBL] [Abstract][Full Text] [Related]
59. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
[TBL] [Abstract][Full Text] [Related]
60. Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.
Bucolo C; Marrazzo G; Platania CB; Romano GL; Drago F; Salomone S
J Pharm Pharmacol; 2014 Jul; 66(7):954-60. PubMed ID: 24697218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]